Lack of efficacy, poor DAS scores may be misinterpreted as a drug failure
Search results for: bisphosphonate
Fallout from False Assumptions in Medicine
How the lack of clear, concise data has impacted opioid prescribing for chronic pain and is clouding the issue of medical recertification
Persistent Symptomatic Hypocalcemia Due to Denosumab: A Case Review
Patients with osteoporosis and impaired renal function are at risk
Drugs Studied for Use in Rheumatoid Arthritis, Weight Loss
Plus, rheumatology drug news from EULAR 2014
Lessons Learned from a Patient with Rheumatoid Arthritis
Sarah Troxell, RN, BSN, imparts what she’s learned about RA and medication management, assembling a team of health professionals and battling other health issues
New Osteoporosis Drugs Show Promise in Therapy Pipeline
Rheumatologists at the ACR’s State-of-the-Art Clinical Symposium in Chicago discuss medication alternatives to bisphosphonates that reduce bone resorption, build bone density and may provide new treatment options
New Insights into CPPD
Progress in research, outcomes, diagnosis, and treatment of calcium pyrophosphate dihydrate crystal deposition disease
Two Inflammatory Conditions—Polymyalgia Rheumatica and Giant Cell Arteritis—Share Clinical Connection
Polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) have common clinical and epidemiologic links, but they need not occur synchronously
ACR/ARHP Annual Meeting 2012: New Research Into Stem Cell Therapy and Drugs May Lead to Breakthrough Treatments for Osteoarthritis
Novel strategies for treating osteoarthritis aim to relieve pain, rebuild or replenish deteriorated cartilage and bone, or to replace the joint through surgery
ACR/ARHP Annual Meeting 2012: New Treatments and Strategies Emerge for Osteoporosis
Rheumatology experts urge caution in using bisphosphonates to prevent bone loss
- « Previous Page
- 1
- …
- 9
- 10
- 11
- 12
- 13
- …
- 15
- Next Page »